![]() |
市场调查报告书
商品编码
1930087
全球空胶囊市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量、未来预测(2026-2034)Empty Capsules Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
预计2025年全球空胶囊市场规模将达36.7亿美元,从2026年的39.1亿美元成长至2034年的65.8亿美元,预测期内复合年增长率(CAGR)为6.74%。北美地区将引领市场,2025年市场占有率将达到33.66%,这主要得益于该地区较高的诊断和治疗率、对胶囊剂型的强烈偏好以及膳食补充剂消费量的增长。
空胶囊是用来封装活性药物成分或非活性物质的外壳。这些胶囊通常使用明胶、羟丙基甲基纤维素(HPMC)、淀粉或普鲁兰多醣等材料製成。 製药厂商扩大采用胶囊製剂、老龄化社会对膳食补充剂的需求不断增长,以及胶囊在化妆品和食品行业的应用日益广泛,这些都是推动市场增长的关键因素。
市场概览及主要亮点
新冠疫情的影响
由于人们为了增强免疫力而增加了维生素和矿物质等营养补充剂的消费,新冠疫情对空胶囊市场产生了积极影响。在此期间,主要市场参与者的收入均有所成长。 例如,Natural Capsules Limited 报告称,其营收从 2019 财年的 830 万美元增长至 2020 财年的 1,080 万美元。疫情过后,市场趋于稳定,製造商正专注于扩大 HPMC 胶囊的生产,以满足国内外市场的需求。
市场趋势
液态填充硬胶囊需求成长
一个显着的市场趋势是,消费者越来越倾向于选择液态填充硬胶囊 (LFHC) 而非软胶囊。软胶囊具有很强的吸湿性,在水分平衡条件下容易变质。为了克服这些局限性,製造商正在转向使用硬明胶和 HPMC 胶囊,这些胶囊具有更好的稳定性、更长的保质期和更高的耐温性。
例如,CapsCanada 于 2022 年 2 月获得液态填充阿斯匹灵胶囊的批准,并于 2021 年 3 月在北美推出液态填充硬胶囊生产服务。这些趋势正在显着推动市场成长。
市场成长驱动因素
扩张策略与新产品发布
随着人口老化加剧,关节、骨骼、消化和肌肉骨骼疾病的发生率不断上升,推动了对药物和营养补充剂的需求。为了应对这一趋势,製造商正在扩大产能、推出新产品并收购竞争对手。
例如,2022 年 12 月,Vantage Nutrition(ACG 集团)收购了 AquaCap,以增强其生产能力。同样,Vivion(Operio 集团)于 2023 年 2 月推出了新的明胶、羟丙甲纤维素 (HPMC) 和普鲁兰胶囊,从而扩展了其产品线。
营养补充胶囊需求成长
由于健康意识的提高、预防医学的普及以及对后疫情时代免疫力的关注,营养补充胶囊的需求正在增长。随着全球人口越来越依赖膳食补充剂进行长期健康管理,对素食胶囊和羟丙基甲基纤维素(HPMC)胶囊的需求也在上升。
根据行业报告显示,约77%的美国成年人服用膳食补充剂,而美国和欧洲近50%的膳食补充剂是素食胶囊。这是推动市场成长的主要因素。
市场限制因子
原物料价格上涨
原物料价格上涨,尤其是明胶和羟丙基甲基纤维素(HPMC)的价格上涨,给市场带来了挑战。除了製药、食品和膳食补充剂产业需求的成长外,地缘政治动盪和原油价格上涨也推高了生产成本。 例如,预计2022年印度HPMC价格将达到每吨6,015.6美元,将影响製造商的利润率。
依类型
截至2024年,由于明胶胶囊在医药领域的广泛应用和较高的生产效率,明胶胶囊将占市场主导地位。然而,由于HPMC胶囊具有适合素食者、低水分含量、稳定性好以及与饮食习惯相容等优点,因此预计其复合年增长率(CAGR)将最高。
依功能
到2026年,速释胶囊将以65.98%的市占率领先,这主要得益于市场对酸剂和抗生素的高需求。由于成本高昂且配方复杂,缓释胶囊和延迟释放胶囊的成长速度预计会较为缓慢。
依最终使用者划分
预计到2026年,製药公司将占市场主导地位,市场占有率高达59.13%,这主要得益于疾病盛行率的上升和政府激励措施。营养补充剂生产商预计将经历最快的增长速度,因为消费者对补充剂的需求日益增长。
The global empty capsules market was valued at USD 3.67 billion in 2025 and is projected to grow from USD 3.91 billion in 2026 to USD 6.58 billion by 2034, registering a CAGR of 6.74% during the forecast period. North America dominated the market with a 33.66% share in 2025, supported by high diagnosis and treatment rates, strong preference for capsule-based dosage forms, and rising consumption of dietary supplements.
Empty capsules are shells used to enclose active pharmaceutical ingredients and inert substances. These capsules are commonly manufactured using gelatin, hydroxypropyl methylcellulose (HPMC), starch, or pullulan. The growing adoption of capsule formulations by pharmaceutical manufacturers, increasing nutraceutical demand among the aging population, and expanding use of capsules in cosmeceutical and food industries are key factors driving market growth.
Market Snapshot & Key Highlights
Impact of COVID-19
The COVID-19 pandemic positively influenced the empty capsules market due to increased consumption of dietary supplements such as vitamins and minerals to boost immunity. Major market players witnessed revenue growth during this period. For instance, Natural Capsules Limited reported revenue growth from USD 8.3 million in FY 2019 to USD 10.8 million in FY 2020. Post-pandemic, the market stabilized, with manufacturers focusing on expanding HPMC capsule production for domestic and international markets.
Market Trends
Rising Demand for Liquid-Filled Hard Capsules
A notable trend in the market is the increasing preference for liquid-filled hard capsules (LFHCs) over softgel capsules. Softgel capsules are hygroscopic and prone to degradation during moisture equilibrium. To overcome these limitations, manufacturers are shifting toward hard gelatin and HPMC capsules, which offer better stability, longer shelf life, and resistance to higher temperatures.
For example, in February 2022, CapsCanada received approval for a liquid-filled aspirin capsule, while in March 2021, the company launched a liquid-filled hard capsule manufacturing service in North America. These developments are contributing significantly to market growth.
Market Growth Drivers
Expansion Strategies and New Product Launches
The growing aging population has led to increased prevalence of joint, bone, gastrointestinal, and musculoskeletal disorders, boosting demand for pharmaceutical and nutraceutical products. This trend has encouraged manufacturers to expand production capacities, launch new products, and acquire competitors.
For instance, in December 2022, Vantage Nutrition (ACG Group) acquired AquaCap, strengthening its manufacturing capabilities. Similarly, Vivion (Operio Group) launched new gelatin, HPMC, and pullulan capsules in February 2023, expanding customer offerings.
Rising Demand for Nutraceutical Capsules
Increasing health awareness, preventive healthcare adoption, and post-pandemic immunity concerns have fueled demand for nutraceutical products in capsule form. A large portion of the global population now prefers dietary supplements for long-term health management, boosting demand for vegetarian and HPMC capsules.
According to industry articles, around 77% of American adults consume dietary supplements, and nearly 50% of nutraceutical products in the U.S. and Europe use vegetarian capsules, significantly supporting market growth.
Market Restraint
Rising Raw Material Prices
The market faces challenges due to inflating prices of raw materials, particularly gelatin and HPMC. Increased demand from pharmaceutical, food, and nutraceutical industries, coupled with geopolitical disruptions and high crude oil prices, has raised production costs. For example, HPMC prices in India reached USD 6,015.6 per metric ton in 2022, impacting manufacturers' profit margins.
By Type
The gelatin segment dominated the market in 2024 due to its widespread pharmaceutical use and manufacturing efficiency. However, HPMC capsules are expected to grow at the highest CAGR owing to their vegetarian nature, low moisture content, stability, and compliance with dietary preferences.
By Functionality
The immediate-release segment led the market with 65.98% share in 2026, driven by high demand for antacids and antibiotics. Sustained and delayed-release capsules are expected to grow at a slower pace due to higher costs and formulation complexities.
By End User
Pharmaceutical companies dominated the market with a 59.13% share in 2026, supported by rising disease prevalence and government incentives. Nutraceutical manufacturers are expected to grow at the fastest rate due to increasing consumer preference for dietary supplements.
Competitive Landscape
The market is consolidated, led by companies such as Lonza, ACG, QUALICAPS, CapsCanada, Natural Capsules Limited, and Nectar Lifesciences. Players are focusing on product innovation, geographic expansion, and TiO2-free capsule development to strengthen their market position.
Conclusion
The global empty capsules market, valued at USD 3.67 billion in 2025, grew to USD 3.91 billion in 2026 and is projected to reach USD 6.58 billion by 2034. Market growth is driven by rising pharmaceutical and nutraceutical demand, technological advancements in capsule delivery, and expanding use of vegetarian capsules. Although raw material price volatility remains a challenge, ongoing innovation, strategic expansions, and increasing healthcare awareness are expected to sustain market growth throughout the forecast period.
By Type, Functionality, End User, and Region
Segmentation By Type
By Functionality
By End User
By Region